HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$21.33
Day range
$20.93 - $21.81
Year range
$18.53 - $51.61
Market cap
1.36B USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 57.19M | 83.83% |
Net income | -51.69M | -82.13% |
Net profit margin | — | — |
Earnings per share | -0.81 | -44.64% |
EBITDA | -57.11M | -83.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 589.83M | 46.12% |
Total assets | 610.17M | 45.50% |
Total liabilities | 75.17M | 14.21% |
Total equity | 535.00M | — |
Shares outstanding | 63.77M | — |
Price to book | 2.54 | — |
Return on assets | -22.59% | — |
Return on capital | -23.42% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -51.69M | -82.13% |
Cash from operations | -54.41M | -60.82% |
Cash from investing | 15.32M | 106.98% |
Cash from financing | 1.53M | -99.45% |
Net change in cash | -37.56M | -260.33% |
Free cash flow | -38.29M | -50.14% |
About
Founded
2016
Headquarters
Website
Employees
152